Whitehawk Therapeutics (WHWK) Shares Outstanding (2010 - 2026)
Whitehawk Therapeutics (WHWK) posted quarterly Shares Outstanding (Entity) of $69.2 million for Q1 2026, up 47.99% year-over-year from $46.8 million in Q1 2025, and up 11.88% quarter-over-quarter from $61.9 million in Q4 2025.
Whitehawk Therapeutics (WHWK) Shares Outstanding (2010 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has reported Shares Outstanding (Entity) for 17 consecutive years, with $69.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 47.99% year-over-year to $69.2 million; the TTM figure through Mar 2026 stood at $69.2 million (up 47.99% YoY), while the FY2025 annual figure was $61.9 million, up 150.75% from the prior year.
- Shares Outstanding (Entity) improved to $69.2 million in Q1 2026 per WHWK's latest filing, from $61.9 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $69.2 million in Q1 2026 and bottomed at $20.9 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $35.5 million across 5 years, with a median of $24.6 million in 2023.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) surged 563.98% — and 2024, when it rose 0.36%.
- Whitehawk Therapeutics' Shares Outstanding (Entity) stood at $24.4 million in 2022, then climbed by 0.49% to $24.6 million in 2023, then advanced by 0.52% to $24.7 million in 2024, then jumped by 150.75% to $61.9 million in 2025, then increased by 11.88% to $69.2 million in 2026.
- Business Quant data shows WHWK's Shares Outstanding (Entity) at $69.2 million in Q1 2026, $61.9 million in Q4 2025, and $69.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Whitehawk Therapeutics | 369.67 Mn | 74.92 Mn | - | 82.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 82.89 Mn |
| Mar 31, 2026 | 69.24 Mn |
| Dec 31, 2025 | 61.89 Mn |
| Sep 30, 2025 | 69.20 Mn |
| Jun 30, 2025 | 69.08 Mn |
| Mar 31, 2025 | 39.64 Mn |
| Dec 31, 2024 | 27.03 Mn |
| Sep 30, 2024 | 27.04 Mn |
| Jun 30, 2024 | 27.01 Mn |
| Mar 31, 2024 | 26.98 Mn |
| Dec 31, 2023 | 26.92 Mn |
| Sep 30, 2023 | 26.95 Mn |
| Jun 30, 2023 | 26.88 Mn |
| Mar 31, 2023 | 26.86 Mn |
| Dec 31, 2022 | 22.51 Mn |
| Sep 30, 2022 | 21.27 Mn |
| Jun 30, 2022 | 20.97 Mn |
| Mar 31, 2022 | 20.91 Mn |
| Dec 31, 2021 | 8.92 Mn |
| Sep 30, 2021 | 9.51 Mn |